Abstract
Background: Aromatase inhibitor (AI) was received by breast cancer
women with estrogen receptor-positive. The estrogen is the main
stimulator for receptor-positive breast cancer cells development and
growth, the adjuvant hormone ablation targeting estrogen can decrease the
likelihood of cancer recurrence and prolong cancer-free survival.
Objective: To determine the effect of this therapy on bone mineral density
of women who received it.
Patients and Methods: It was identified 100 women with local or
regional breast cancer diagnosed and who received AI therapy in the
January 2022 to February 2023 from Baqubah teaching hospital/Oncology
Centre. It was used DEXA scan to determine the bone minerals density of
50 women after different years from receiving hormonal therapy and other
50 breast cancer women before receiving hormonal therapy.
Results: It was shown that there is a significant difference (p<0.0001) in the
spine and hip density of breast cancer women who received AIs compare
with the bone density of other breast cancer women who did not receive it.
Conclusion: It can conclude that Als plays an essential role for
osteoporosis that reduce the quality of health and increase the risk of
fraction in the breast cancer women
women with estrogen receptor-positive. The estrogen is the main
stimulator for receptor-positive breast cancer cells development and
growth, the adjuvant hormone ablation targeting estrogen can decrease the
likelihood of cancer recurrence and prolong cancer-free survival.
Objective: To determine the effect of this therapy on bone mineral density
of women who received it.
Patients and Methods: It was identified 100 women with local or
regional breast cancer diagnosed and who received AI therapy in the
January 2022 to February 2023 from Baqubah teaching hospital/Oncology
Centre. It was used DEXA scan to determine the bone minerals density of
50 women after different years from receiving hormonal therapy and other
50 breast cancer women before receiving hormonal therapy.
Results: It was shown that there is a significant difference (p<0.0001) in the
spine and hip density of breast cancer women who received AIs compare
with the bone density of other breast cancer women who did not receive it.
Conclusion: It can conclude that Als plays an essential role for
osteoporosis that reduce the quality of health and increase the risk of
fraction in the breast cancer women
Keywords
Bone mineral
Breast Cancer
Hormonal therapy
Osteoporosis.